Table 2.

Frequencies of the first occurrence and all primary and secondary outcome events during follow-up

			Start antiplatelet therapy (n=268)		Avoid antiplatelet therapy (n=268)
			First event	All events	First event	All events
Primary outcome
Recurrent symptomatic spontaneous intracerebral haemorrhage			12 (4%)	14	23 (9%)	27
Secondary outcomes
Arterial events
	Major haemorrhagic events
		Spontaneous or traumatic intracranial extracerebral haemorrhage	4 (1%)	4	3 (1%)	3
		Major extracranial haemorrhage	4 (1%)	4	0	0
	Major occlusive vascular events
		Ischaemic stroke	19 (7%)	21	27 (10%)	28
		Myocardial infarction	5 (2%)	5	8 (3%)	9
		Peripheral arterial occlusion	5 (2%)	5	2 (1%)	2
		Transient ischaemic attack	11 (4%)	12	18 (7%)	23
		Retinal arterial occlusion	0	0	0	0
		Mesenteric ischaemia	0	0	0	0
	Stroke of uncertain subtype		0	0	1 (<1%)	1
Carotid, coronary, or peripheral arterial revascularisation procedures			12 (4%)	12	5 (2%)	5
Venous events
	Deep vein thrombosis		6 (2%)	6	2 (1%)	2
	Pulmonary embolism		4 (1%)	4	1 (<1%)	1
Deaths
	Fatal outcome event		10 (4%)	10	19 (7%)	19
	Other cardiovascular death		6 (2%)	6	8 (3%)	8
	Sudden cardiac death		2 (1%)	2	0	0
	Non-cardiovascular death		35 (13%)	35	22 (8%)	22
	Undetermined cause		1 (<1%)	1	1 (<1%)	1

Data are n (%) or n.